JP2001521902A5 - - Google Patents

Download PDF

Info

Publication number: JP2001521902A5
Authority: JP; Japan
Prior art keywords: pharmaceutical composition; composition according; crosslinking agent; polymer; monomer
Prior art date: 1998-10-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2000518676A

Other languages

English (en)

Japanese (ja)

Other versions

JP2001521902A (ja

JP4452402B2 (ja

Filing date

1998-10-26

Publication date

2006-01-05

1997-11-05 Priority claimed from US08/964,956 external-priority patent/US5985938A/en

1998-10-26 Application filed filed Critical

2001-11-13 Publication of JP2001521902A publication Critical patent/JP2001521902A/ja

2006-01-05 Publication of JP2001521902A5 publication Critical patent/JP2001521902A5/ja

2010-04-21 Application granted granted Critical

2010-04-21 Publication of JP4452402B2 publication Critical patent/JP4452402B2/ja

2018-10-26 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

239000008194 pharmaceutical composition Substances 0.000 description 25
239000003431 cross linking reagent Substances 0.000 description 20
229920000642 polymer Polymers 0.000 description 10
239000000178 monomer Substances 0.000 description 8
0 CC(CC(C)(C)C1)C1[N+](*)* Chemical compound CC(CC(C)(C)C1)C1[N+](*)* 0.000 description 4
BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 4
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
229920001519 homopolymer Polymers 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
125000003282 alkyl amino group Chemical group 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
229920006037 cross link polymer Polymers 0.000 description 1
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
238000000034 method Methods 0.000 description 1
229920000083 poly(allylamine) Polymers 0.000 description 1

JP2000518676A 1997-11-05 1998-10-26 蓚酸塩を低減させるための脂肪族ポリアミン類の使用 Expired - Lifetime JP4452402B2 (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/964,956		1997-11-05
US08/964,956 US5985938A (en)	1997-11-05	1997-11-05	Method for reducing oxalate
PCT/US1998/022606 WO1999022744A1 (en)	1997-11-05	1998-10-26	Use of aliphatic polyamines for reducing oxalate

Publications (3)

Publication Number	Publication Date
JP2001521902A JP2001521902A (ja)	2001-11-13
JP2001521902A5 true JP2001521902A5 (2)	2006-01-05
JP4452402B2 JP4452402B2 (ja)	2010-04-21

Family

ID=25509224

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2000518676A Expired - Lifetime JP4452402B2 (ja)	1997-11-05	1998-10-26	蓚酸塩を低減させるための脂肪族ポリアミン類の使用

Country Status (10)

Country	Link
US (3)	US5985938A (2)
EP (2)	EP1645278A3 (2)
JP (1)	JP4452402B2 (2)
AR (1)	AR016001A1 (2)
AU (1)	AU1364799A (2)
CA (1)	CA2349620C (2)
DE (1)	DE69833134T2 (2)
TW (1)	TW585772B (2)
WO (1)	WO1999022744A1 (2)
ZA (1)	ZA989671B (2)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5667775A (en) *	1993-08-11	1997-09-16	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
US8486389B2 (en)	1997-05-23	2013-07-16	Oxthera, Inc.	Compositions and methods for treating or preventing oxalate-related disease
US6566407B2 (en) *	1997-11-05	2003-05-20	Geltex Pharmaceuticals, Inc.	Method for reducing oxalate
US5985938A (en) *	1997-11-05	1999-11-16	Geltex Pharmaceuticals, Inc.	Method for reducing oxalate
US20020054903A1 (en) *	1999-10-19	2002-05-09	Joseph Tyler	Direct compression polymer tablet core
US6733780B1 (en)	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core
GB9927088D0 (en) *	1999-11-17	2000-01-12	Secr Defence	Use of poly(diallylamine) polymers
DE10028167B4 (de) *	2000-06-09	2004-02-19	Storch, Rüdiger, Dr.	Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
CA2444046C (en) *	2001-04-18	2011-06-07	Steven K. Burke	Use of colesevelam in reducing serum glucose
WO2002085380A1 (en) *	2001-04-18	2002-10-31	Geltex Pharmaceuticals, Inc.	Method for treating gout and reducing serum uric acid
EP1923064B1 (en)	2001-04-18	2017-06-28	Genzyme Corporation	Use of amine polymer for lowering serum glucose
BR0209133A (pt) *	2001-04-18	2004-06-15	Genzyme Corp	Método para tratar gota e para reduzir os nìveis de ácido úrico n0 sangue
AU2002252632B2 (en) *	2001-04-18	2004-09-23	Genzyme Corporation	Low salt forms of polyallylamine
EP1379259A1 (en) *	2001-04-18	2004-01-14	Genzyme Corporation	Methods of treating syndrome x with aliphatic polyamines
WO2002085379A1 (en) *	2001-04-18	2002-10-31	Geltex Pharmaceuticals, Inc.	Method for improving vascular access in patients with vascular shunts
DK1389102T3 (da)	2001-04-23	2011-06-06	Shire Int Licensing Bv	Anvendelse af lanthancarbonat til forebyggelse af nyresten
US7041280B2 (en) *	2001-06-29	2006-05-09	Genzyme Corporation	Aryl boronate functionalized polymers for treating obesity
CN1578833B (zh) *	2001-10-05	2010-05-26	奥克斯赛拉公司	降低流体中草酸(盐)浓度的材料和方法
ATE389684T1 (de) *	2001-10-09	2008-04-15	Genzyme Corp	Verfahren zum reinigen und trocknen von polymerhydrogelen
US6600011B2 (en) *	2001-10-09	2003-07-29	Genzyme Corporation	Process for purification and drying of polymer hydrogels
US7220406B2 (en) *	2002-10-22	2007-05-22	Genzyme Corporation	Method for promoting bone formation
US7767768B2 (en) *	2003-11-03	2010-08-03	Ilypsa, Inc.	Crosslinked amine polymers
US7385012B2 (en)	2003-11-03	2008-06-10	Ilypsa, Inc.	Polyamine polymers
US7608674B2 (en) *	2003-11-03	2009-10-27	Ilypsa, Inc.	Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7449605B2 (en) *	2003-11-03	2008-11-11	Ilypsa, Inc.	Crosslinked amine polymers
US7459502B2 (en) *	2003-11-03	2008-12-02	Ilypsa, Inc.	Pharmaceutical compositions comprising crosslinked polyamine polymers
US7335795B2 (en)	2004-03-22	2008-02-26	Ilypsa, Inc.	Crosslinked amine polymers
PT2184059E (pt)	2004-03-30	2012-07-06	Relypsa Inc	Polímeros de ligação a ião e seus usos
EP1755655A4 (en) *	2004-05-07	2011-03-30	Oxthera Inc	METHOD AND COMPOSITIONS FOR REDUCING OXALATE CONCENTRATIONS
US20060177415A1 (en) *	2004-11-01	2006-08-10	Burke Steven K	Once a day formulation for phosphate binders
US7985418B2 (en)	2004-11-01	2011-07-26	Genzyme Corporation	Aliphatic amine polymer salts for tableting
WO2006072054A1 (en) *	2004-12-30	2006-07-06	Genzyme Corporation	Zinc-containing treatments for hyperphosphatemia
US8986669B2 (en)	2005-09-02	2015-03-24	Genzyme Corporation	Method for removing phosphate and polymer used therefore
EP3000460A1 (en) *	2005-09-15	2016-03-30	Genzyme Corporation	Sachet formulation for amine polymers
EP1945196A2 (en) *	2005-11-08	2008-07-23	Genzyme Corporation	Magnesium-containing polymers for hyperphosphatemia
PT1962873E (pt) *	2005-12-14	2013-08-29	Oxthera Inc	Composições farmacêuticas compreendendo bactérias redutoras de oxalato
ES2362897T3 (es)	2005-12-16	2011-07-14	Oxthera, Inc.	Composiciones y métodos para reducción del oxalato.
EP2016114A2 (en) *	2006-05-05	2009-01-21	Genzyme Corporation	Amine condensation polymers as phosphate sequestrants
WO2008005217A2 (en) *	2006-07-05	2008-01-10	Genzyme Corporation	Iron(ii)-containing treatments for hyperphosphatemia
CA2655873C (en)	2006-07-14	2017-10-17	Wisconsin Alumni Research Foundation	Adsorptive membranes for trapping viruses
AU2007275711A1 (en) *	2006-07-18	2008-01-24	Genzyme Corporation	Amine dendrimers
PT2046373E (pt)	2006-08-02	2013-05-06	Althea Technologies Inc	Oxalato descarboxilase cristalizada e métodos de utilização
EP2066293A2 (en)	2006-09-29	2009-06-10	Genzyme Corporation	Amide dendrimer compositions
CN101568349B (zh) *	2006-10-25	2012-09-19	威斯康星大学校友研究基金会	减少磷酸盐吸收的方法
JP2010508281A (ja)	2006-10-26	2010-03-18	ウィスコンシン・アラムナイ・リサーチ・ファウンデイション	リン酸塩吸収の低減方法
US8163799B2 (en)	2006-12-14	2012-04-24	Genzyme Corporation	Amido-amine polymer compositions
JP2010519298A (ja) *	2007-02-23	2010-06-03	ゲンズイメコーポレーション	アミンポリマー組成物
EP2131820A1 (en) *	2007-03-08	2009-12-16	Genzyme Corporation	Sulfone polymer compositions
WO2008113364A2 (en) *	2007-03-20	2008-09-25	Recepticon Aps	Amino derivatives to prevent nephrotoxicity and cancer
EP2152277A1 (en) *	2007-04-27	2010-02-17	Genzyme Corporation	Amido-amine dendrimer compositions
WO2009078958A1 (en) *	2007-12-14	2009-06-25	Genzyme Corporation	Coated pharmaceutical compositions
FR2928373B1 (fr)	2008-03-05	2010-12-31	Centre Nat Rech Scient	Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
US20110142952A1 (en) *	2008-06-20	2011-06-16	Harris David J	Pharmaceutical Compositions
WO2010123039A1 (ja) *	2009-04-21	2010-10-28	株式会社医学生物学研究所	生物学的材料の不動化を行うための組成物
WO2014113648A1 (en)	2013-01-18	2014-07-24	Allena Pharmaceuticals, Inc.	Crystallized oxalate decarboxylase and methods of use
HK1220607A1 (zh) *	2013-03-15	2017-05-12	Genzyme Corporation	晚期糖化终产物(age)前体的螯合剂
DK3003358T3 (da)	2013-06-07	2021-06-21	Allena Pharmaceuticals Inc	Sammensætninger og anordninger til dialyse
US10435528B2 (en)	2013-09-17	2019-10-08	Aquanano Llc	High-capacity anion exchange materials
MA41202A (fr)	2014-12-18	2017-10-24	Genzyme Corp	Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
EP3277099B9 (en)	2015-04-02	2024-05-29	Oxidien Pharmaceuticals, Llc	High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
GB201718803D0 (en) *	2017-11-14	2017-12-27	Phoenix Molecular Pte Ltd	Method for isolation of nucleic acids
WO2019236858A1 (en) *	2018-06-06	2019-12-12	The Board Of Trustees Of The University Of Illinois	Zwitterionic biocompatible polymers, methods, and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4198396A (en) *	1974-07-03	1980-04-15	Warren-Teed Laboratories, Inc.	Dissolution of gallstones
US4143130A (en) *	1977-08-29	1979-03-06	Warren-Teed Laboratories, Inc.	Method for treating kidney stones
JPS60202869A (ja) *	1984-03-26	1985-10-14	Ajinomoto Co Inc	大環状ポリアミン誘導体及びその用途
DE3727082A1 (de) *	1987-08-14	1989-02-23	Goedecke Ag	Pharmazeutische zubereitungen zur behandlung der urolithiasis
US5244913A (en) *	1991-11-19	1993-09-14	Baxter International Inc.	Compositions and methods for dissolving body calculi
US5487888A (en) *	1993-05-20	1996-01-30	Geltex, Inc.	Iron-binding polymers for oral administration
US5703188A (en) *	1993-06-02	1997-12-30	Geltex Pharmaceuticals, Inc.	Process for removing bile salts from a patient and compositions therefor
US5607669A (en) *	1994-06-10	1997-03-04	Geltex Pharmaceuticals, Inc.	Amine polymer sequestrant and method of cholesterol depletion
US5618530A (en) *	1994-06-10	1997-04-08	Geltex Pharmaceuticals, Inc.	Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5624963A (en) *	1993-06-02	1997-04-29	Geltex Pharmaceuticals, Inc.	Process for removing bile salts from a patient and compositions therefor
US5667775A (en) *	1993-08-11	1997-09-16	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
US5496545A (en) *	1993-08-11	1996-03-05	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
TW474813B (en) *	1994-06-10	2002-02-01	Geltex Pharma Inc	Alkylated composition for removing bile salts from a patient
EP0934352B1 (en) *	1996-10-23	2007-05-02	Dow Global Technologies Inc.	Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
US5985938A (en) *	1997-11-05	1999-11-16	Geltex Pharmaceuticals, Inc.	Method for reducing oxalate

1997
- 1997-11-05 US US08/964,956 patent/US5985938A/en not_active Expired - Lifetime
1998
- 1998-10-23 ZA ZA989671A patent/ZA989671B/xx unknown
- 1998-10-26 JP JP2000518676A patent/JP4452402B2/ja not_active Expired - Lifetime
- 1998-10-26 EP EP05076677A patent/EP1645278A3/en not_active Withdrawn
- 1998-10-26 CA CA002349620A patent/CA2349620C/en not_active Expired - Fee Related
- 1998-10-26 EP EP98957371A patent/EP1044008B1/en not_active Expired - Lifetime
- 1998-10-26 DE DE69833134T patent/DE69833134T2/de not_active Expired - Lifetime
- 1998-10-26 WO PCT/US1998/022606 patent/WO1999022744A1/en not_active Ceased
- 1998-10-26 AU AU13647/99A patent/AU1364799A/en not_active Abandoned
- 1998-11-03 AR ARP980105513A patent/AR016001A1/es unknown
- 1998-11-03 TW TW087118238A patent/TW585772B/zh not_active IP Right Cessation
1999
- 1999-07-22 US US09/359,226 patent/US6177478B1/en not_active Expired - Lifetime
2000
- 2000-09-25 US US09/668,874 patent/US6281252B1/en not_active Expired - Lifetime

Publication	Publication Date	Title
JP2001521902A5 (2)	2006-01-05
JP2001521890A5 (2)	2006-01-05
WO1999033452A3 (en)	1999-10-21	Amine-containing copolymers as bile acid sequestrants
JP2004535384A5 (2)	2005-12-22
JP2004528332A5 (2)	2005-12-22
JP2005533531A5 (2)	2006-05-25
JP2004526778A5 (2)	2005-12-22
JPH11152398A5 (2)	2005-11-04
CA2444046A1 (en)	2002-10-31	Use of colesevelam in reducing serum glucose
JP2002541278A5 (2)	2007-05-17
EP1645278A3 (en)	2007-11-14	Use of aliphatic polyamines for reducing oxalate
JP2004520473A5 (2)	2005-12-22
JP2005517062A5 (2)	2006-03-23
ATE273341T1 (de)	2004-08-15	Strikt alternierende poly(alkylenoxid)copolymere
CA1237229A (en)	1988-05-24	Method for making conductive member for skin contact electrode containing sulfonated polymer material
JP2001509529A5 (2)	2006-01-05
CA2050899A1 (en)	1991-09-10	Curable composition
RU96124822A (ru)	1999-04-10	Поперечно-сшитые полимеры для удаления из организма человека солей желчных кислот
ATE288956T1 (de)	2005-02-15	Verwendung eines amphoteren polymeres zur behandlung ausgewählter harter oberflächen
ES2138231T3 (es)	2000-01-01	Polimeros radio-opacos y metodos para su preparacion.
HUP0004279A2 (hu)	2002-03-28	Eljárás hiperkoleszterinémia kezelésére helyettesített poli(diallil-amin)nal
JP2003514935A5 (2)	2007-12-20
JP2003518152A5 (2)	2008-02-21
JP2004244633A5 (2)	2011-03-31
JP2008543602A5 (2)	2010-06-17